Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-12-01

FDA Approved: METHENAMINE HIPPURATE — Original Application (Jubilant Cadista Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Jubilant Cadista Pharmaceuticals Inc.'s original application for methenamine hippurate, a urinary tract antiseptic, for the prevention of urinary t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methenamine Hippurate (Methenamine hippurate)

Snippet

ORIG AP for METHENAMINE HIPPURATE (METHENAMINE HIPPURATE)